An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00991757
Recruitment Status : Completed
First Posted : October 8, 2009
Last Update Posted : June 18, 2013
Information provided by (Responsible Party):
SK Life Science

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2010
  Actual Study Completion Date : October 2010
  Certification/Extension First Submitted : January 15, 2013